Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cerebrospinal fluid amyloid β and tau in LRRK2 mutation carriers.
Aasly JO, Shi M, Sossi V, Stewart T, Johansen KK, Wszolek ZK, Uitti RJ, Hasegawa K, Yokoyama T, Zabetian CP, Kim HM, Leverenz JB, Ginghina C, Armaly J, Edwards KL, Snapinn KW, Stoessl AJ, Zhang J. Aasly JO, et al. Among authors: leverenz jb. Neurology. 2012 Jan 3;78(1):55-61. doi: 10.1212/WNL.0b013e31823ed101. Epub 2011 Dec 14. Neurology. 2012. PMID: 22170881 Free PMC article.
Analysis of the LRRK2 G2019S mutation in Alzheimer Disease.
Zabetian CP, Lauricella CJ, Tsuang DW, Leverenz JB, Schellenberg GD, Payami H. Zabetian CP, et al. Among authors: leverenz jb. Arch Neurol. 2006 Jan;63(1):156-7. doi: 10.1001/archneur.63.1.156. Arch Neurol. 2006. PMID: 16401756 Free PMC article. No abstract available.
Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.
Abdi F, Quinn JF, Jankovic J, McIntosh M, Leverenz JB, Peskind E, Nixon R, Nutt J, Chung K, Zabetian C, Samii A, Lin M, Hattan S, Pan C, Wang Y, Jin J, Zhu D, Li GJ, Liu Y, Waichunas D, Montine TJ, Zhang J. Abdi F, et al. Among authors: leverenz jb. J Alzheimers Dis. 2006 Aug;9(3):293-348. doi: 10.3233/jad-2006-9309. J Alzheimers Dis. 2006. PMID: 16914840
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers.
Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VM, Leverenz JB, Masliah E, McKeith IG, Nussbaum RL, Olanow CW, Ravina BM, Singleton AB, Tanner CM, Trojanowski JQ, Wszolek ZK; DLB/PDD Working Group. Lippa CF, et al. Among authors: leverenz jb. Neurology. 2007 Mar 13;68(11):812-9. doi: 10.1212/01.wnl.0000256715.13907.d3. Neurology. 2007. PMID: 17353469 Review.
Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders.
Mata IF, Samii A, Schneer SH, Roberts JW, Griffith A, Leis BC, Schellenberg GD, Sidransky E, Bird TD, Leverenz JB, Tsuang D, Zabetian CP. Mata IF, et al. Among authors: leverenz jb. Arch Neurol. 2008 Mar;65(3):379-82. doi: 10.1001/archneurol.2007.68. Arch Neurol. 2008. PMID: 18332251 Free PMC article.
Glycoproteomics in neurodegenerative diseases.
Hwang H, Zhang J, Chung KA, Leverenz JB, Zabetian CP, Peskind ER, Jankovic J, Su Z, Hancock AM, Pan C, Montine TJ, Pan S, Nutt J, Albin R, Gearing M, Beyer RP, Shi M, Zhang J. Hwang H, et al. Among authors: leverenz jb. Mass Spectrom Rev. 2010 Jan-Feb;29(1):79-125. doi: 10.1002/mas.20221. Mass Spectrom Rev. 2010. PMID: 19358229 Free PMC article. Review.
294 results